Correlation Between Unicycive Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Unicycive Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Ikena Oncology.
Diversification Opportunities for Unicycive Therapeutics and Ikena Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Unicycive and Ikena is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Ikena Oncology
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.2 times more return on investment than Ikena Oncology. However, Unicycive Therapeutics is 1.2 times more volatile than Ikena Oncology. It trades about 0.03 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.02 per unit of risk. If you would invest 82.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would lose (2.00) from holding Unicycive Therapeutics or give up 2.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| Unicycive Therapeutics |
| Ikena Oncology |
Unicycive Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Ikena Oncology
The main advantage of trading using opposite Unicycive Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |